Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ruchi NAGARKAR"'
Autor:
Irene E. SUCQUART, Ruchi NAGARKAR, Melissa C. EDWARDS, Valentina RODRIGUEZ PARIS, Ali AFLATOUNIAN, Michael J. BERTOLDO, Rebecca E. CAMPBELL, Denovan P. BEGG, David J. HANDELSMAN, Vasantha PADMANABHAN, Richard A. ANDERSON, Robert B. GILCHRIST, Kirsty A. WALTERS
Publikováno v:
Fertility & Reproduction, Vol 04, Iss 03n04, Pp 160-160 (2022)
Background: Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine condition affecting up to 20% of reproductively aged women worldwide. Owing to an ambiguous etiology and complicated pathophysiology, current PCOS treatments remain purely symp
Externí odkaz:
https://doaj.org/article/ea7e67a813874cc585e156f6b3c1c55a
Autor:
Vasantha Padmanabhan, Irene E Sucquart, Ali Aflatounian, Robert B. Gilchrist, Ruchi Nagarkar, Melissa C Edwards, Valentina Rodriguez Paris, David J. Handelsman, Michael J. Bertoldo, Rebecca Campbell, Kirsty A Walters, Richard A. Anderson, Denovan P. Begg
Publikováno v:
Sucquart, I E, Nagarkar, R, Edwards, M C, Rodriguez Paris, V, Aflatounian, A, Bertoldo, M J, Campbell, R E, Gilchrist, R B, Begg, D P, Handelsman, D J, Padmanabhan, V, Anderson, R A & Walters, K A 2021, ' Neurokinin 3 receptor antagonism ameliorates key metabolic features in a hyperandrogenic PCOS mouse model ', Endocrinology . https://doi.org/10.1210/endocr/bqab020
Polycystic ovary syndrome (PCOS) is a prevalent endocrine condition characterized by a range of endocrine, reproductive, and metabolic abnormalities. At present, management of women with PCOS is suboptimal as treatment is only symptomatic. Clinical a